Literature DB >> 25251880

Blood transfusion transmission of the tick-borne relapsing fever spirochete Borrelia miyamotoi in mice.

Peter J Krause1, Jeanne E Hendrickson, Tanner K Steeves, Durland Fish.   

Abstract

BACKGROUND: Borrelia miyamotoi, a recently discovered relapsing fever spirochete, occurs in hard-bodied ticks wherever Lyme disease is endemic. Human infection is associated with relapsing fever and can cause meningoencephalitis in immunocompromised patients. A few cases of transfusion transmission of other relapsing fever spirochete species have been reported but none for B. miyamotoi. Our objective was to determine whether B. miyamotoi transfusion transmission could occur in a murine transfusion model. Herein, we report transfusion transmission of B. miyamotoi through fresh or stored red blood cells (RBCs) in a mouse model. STUDY DESIGN AND METHODS: Inbred mice were transfused with B. miyamotoi-infected murine blood that was either freshly collected or stored for 7 days before transfusion. Recipient blood was then longitudinally examined after transfusion by smear and wet mount for evidence of spirochetemia.
RESULTS: Motile spirochetes were observed in immunocompromised (SCID) mouse recipients for 28 days after transfusion of both fresh and stored murine B. miyamotoi-infected RBCs. Transient spirochetemia was observed in immunocompetent DBA/2 and C57BL/6 mice, with spirochete clearance occurring within 5 days after transfusion.
CONCLUSION: These data demonstrate that transfusion transmission of B. miyamotoi can occur in mice and suggest that it also may occur in humans.
© 2014 AABB.

Entities:  

Mesh:

Year:  2014        PMID: 25251880     DOI: 10.1111/trf.12879

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Borrelia miyamotoi infection in nature and in humans.

Authors:  P J Krause; D Fish; S Narasimhan; A G Barbour
Journal:  Clin Microbiol Infect       Date:  2015-02-18       Impact factor: 8.067

2.  Infection and seroprevalence of Borrelia persica in domestic cats and dogs in Israel.

Authors:  Gad Baneth; Ann Dvorkin; Bar Ben-Shitrit; Gabriela Kleinerman; Harold Salant; Reinhard K Straubinger; Yaarit Nachum-Biala
Journal:  Parasit Vectors       Date:  2022-05-10       Impact factor: 4.047

Review 3.  Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever.

Authors:  Sam R Telford; Heidi K Goethert; Philip J Molloy; Victor P Berardi; Hanumara Ram Chowdri; Joseph L Gugliotta; Timothy J Lepore
Journal:  Clin Lab Med       Date:  2015-09-18       Impact factor: 1.935

4.  Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011-2014: a cross-sectional study.

Authors:  Kamran Kadkhoda; Cecilia Dumouchel; Janna Brancato; Ainsley Gretchen; Peter J Krause
Journal:  CMAJ Open       Date:  2017-09-06

5.  Variable Major Proteins as Targets for Specific Antibodies against Borrelia miyamotoi.

Authors:  Alex Wagemakers; Joris Koetsveld; Sukanya Narasimhan; Melvin Wickel; Kathleen Deponte; Boris Bleijlevens; Seta Jahfari; Hein Sprong; Lyudmila S Karan; Denis S Sarksyan; Tom van der Poll; Linda K Bockenstedt; Adriaan D Bins; Alexander E Platonov; Erol Fikrig; Joppe W Hovius
Journal:  J Immunol       Date:  2016-04-13       Impact factor: 5.422

Review 6.  Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi.

Authors:  Brandee L Stone; Catherine A Brissette
Journal:  Front Immunol       Date:  2017-01-19       Impact factor: 7.561

Review 7.  Relapsing Fevers: Neglected Tick-Borne Diseases.

Authors:  Emilie Talagrand-Reboul; Pierre H Boyer; Sven Bergström; Laurence Vial; Nathalie Boulanger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

8.  Rapid clearance of Borrelia burgdorferi from the blood circulation.

Authors:  Liucun Liang; Jinyong Wang; Lucas Schorter; Thu Phong Nguyen Trong; Shari Fell; Sebastian Ulrich; Reinhard K Straubinger
Journal:  Parasit Vectors       Date:  2020-04-21       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.